Based on recommendations of an expert panel, the Delhi government is likely to come out with a policy this week to cap profit margins of city hospitals on drugs and devices, according to sources.
The nine-member panel, headed by Director-General of Health Services Kirti Bhushan, was set up by the Arvind Kejriwal government on December 13 last year.
"We submitted the recommendations about two months ago and the new policy on capping of profit margin by hospitals should be out by this week," a top official told PTI.
The move comes after a public outrage on the death of a child due to dengue last year at a private hospital in Gurgaon, which charged the family around Rs 16 lakh for treatment.
The committee had suggested capping the profit margin for drugs and devices at a maximum of 50 per cent above the manufacturing price or procurement cost, whichever was lower, the official said.
The panel members include the then Indian Medical Association president Dr K K Aggarwal, Delhi Medical Council president Dr Arun Gupta, former president of Delhi Medical Association Dr R K Gupta, and experts, and senior bureaucrats from the government.
"Health Minister Satyendar Jain is likely to announce the policy on Wednesday," a source in the health department said.
On December 13, Jain, while announcing the constitution of the panel, had said that it would also recommend the Delhi government norms to be followed by city hospitals, including in medical investigation and for behavioural protocols.
However, sources said, the announcement, as of now would only pertain to the policy of capping of profit margins.
The National Pharmaceutical Pricing Authority (NPPA) had in December said that the private hospital had charged as high as 1,700 per cent margin on consumables and medicines used for the treatment of the dengue patient, a seven-year-old girl, who subsequently died of the illness.
Jain, in his December press conference, had said, "They will not be mere recommendations. The Delhi government will use them to come up with protocols related to medical services."
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
